Study on the Contribution of the Genetic Tumor Profile Obtained by Circulating Tumor DNA Analysis in the Multidisciplinary Molecular Biology Meeting of Eastern PACA

Exclusion Criteria

• •Previous or concurrent cancer diagnosed or treated within the last 5 years, except for in situ carcinoma of the cervix, basal cell or squamous cell carcinoma of the skin, and adequately treated in situ carcinoma of the bladder.
• •Severe or uncontrolled systemic disease.
• •Any condition which, in the investigator's judgment (geographical, social, or psychological factors, etc.), makes the patient unable to comply with study follow-up and procedures.
• •Patient considered a vulnerable person; vulnerable persons are defined in Articles L1121-5 to L1121-8:
• •* Pregnant women, women in labor, and breastfeeding mothers,
• •* Persons deprived of liberty by judicial or administrative decision, individuals hospitalized without consent under Articles L. 3212-1 and L. 3213-1 who do not fall under the provisions of Article L. 1121-8,
• •* Persons admitted to a healthcare or social institution for reasons other than research,
• •* Adults unable to give their consent.